Clinical Trials
2 trialsNCT03972527 2024-08-21
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
MuReva Phototherapy Inc.
Phase NA Completed
NCT02480114 2021-02-18
Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
Vanderbilt-Ingram Cancer Center
Phase 3 Completed